Our new study is published in Oncotarget, featuring a CRISPR-screen to test the impact of RASGAP deficiencies on anti-EGFR therapy-resistance in colorectal cancer. Fantastic work by Jasmin to make genetic knock-out organoids and optimize biochemical analysis of the MAPK pathway in these models

Categories: News